MSP hires site director from AZ
Manchester Science Partnerships has added to its senior management team with the recruitment of Dr Chris Doherty as site director for Alderley Park in Cheshire, joining from from previous site owner AstraZeneca.
Doherty will oversee the continuing plans and strategy for Alderley Park and the core Manchester Corridor sites along Oxford Road.
Rowena Burns, chief executive of MSP, said: "MSP is going from strength to strength. In the last two years alone we have increased profits 210%, acquired Alderley Park in May this year, recently launched Citylabs, received planning for our 70,000 sq ft 'Heart of the Park' new-build at our core MSP site and we have ambitious plans for future growth both at our 'Corridor' sites and at Alderley Park.
"As such we have made two key appointments to add to the senior team. The first is Dr Chris Doherty, joining us as a site director for Alderley Park, who will be responsible for the operation of the site, and for driving our life sciences strategy & sales, so that Alderley Park continues as an internationally important bio-science campus. Chris joins us from Astrazeneca and brings with him over 25 years' industry expertise.
"The second is an internal promotion for Thomas Renn, who has been appointed associate commercial director and whose role will be to lead the integration of Citylabs into our portfolio and to oversee the delivery of our core growth plan on the Oxford Road corridor sites in Manchester to take us from 250,000 sq ft to 1m sq ft. Thomas has been with Bruntwood for seven years, working across the construction, procurement and commercial departments."
Doherty said: "I am very happy to be joining the management team at Manchester Science Partnerships and to use my experience from within the sector to help shape and deliver our strategy to create a vibrant community of successful bio-science businesses."
MSP is a Manchester based public-private partnership and the UK's largest science park operator. MSP's shareholders are Bruntwood, University of Manchester, Manchester Metropolitan University, Central Manchester University Hospitals NHS Foundation Trust and Manchester, Cheshire East and Salford City Councils.
